Passion for innovation and excellence drives the Research & Development activity at Lincoln Pharma. The company has a strong R&D team including 40 plus scientists. Company’s innovation program is spearheaded by over 20 researchers working on differentiated medicines for the future. Company’s key strength is embedded in its cutting-edge research and development capabilities and It has successfully filled 25 plus patent applications and is awarded seven patents.
Company develops and manufactures affordable and innovative medicines for healthier lives. The company has developed 600 plus formulations in 20 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynecology, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria among others. The company markets its products in the Indian market and also exports to more than 50 Countries.
Healthcare for All
Company has developed many new drug delivery dosage forms over years and has a track record of launching many first-of-its-kind innovative products. Company works with a vision for nurturing innovations and bringing them to Indian patients at an affordable cost to create “Healthcare for All”.
We are strongly research focused and has a program for developing various generic chemical entities, dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. We have patented number of NDDS type of products, which were successfully launched commercially.
Company has Developed many new NDDS formulations and introduced as a first time in India
Anti-Fungal Vaginal Spray
Diclofenac Rectal Spray
Sildenafil Oral Spray
Ondansetron Hydrochloride Oral Spray (DOMI-UP)
Paracetamol 1000mg Programmed Release Tablet (PA-12)
Micronized Progesterone Vaginal Spray (PROLIN)
Namcold DX Oral Suspension
Caroverine Injection & Capsule (TINNEX)
First one to introduce TINNEX for the relief of Tinnitus, tie up with PHAFAG-AG, Switzerland
Different Dosage Formsin Development Portfolio
Capsules
- Immediate Release Capsule
- Sustained Release Capsule
- Delayed Release Capsule
Modified Release
- Sustained Release tablet
- Delayed Release tablet
Parenteral
- Dry Powder for injection
- Liquid (vial and Ampoule)
- Ophthalmic preparation
Immediate Release
- Film Coated
- Uncoated
- Mouth dissolving
- Dispersible
- Chewable
- Sachet
- Oral Films
Topical
- Gels
- Cream
- Ointments
- Lotions
- Sterile Ointment
Liquid Oral
- Dry Syrup for oral Suspension.
- Oral Suspension
- Oral Solution
- Sustained Release Suspension
The Formulation R & D Capability includes :
The group is well supported by analytical development team which is committed for development of analytical methodologies that provide sensitive, precise, rugged & accurate data in minimum time. Key activities include development & validation of various analytical test procedures for Assay, Content Uniformity, Dissolution, Related Substances, Residual Solvents, other in-house test procedures & finalization of their Specifications which will adequately evaluate desire quality attributes.
- Design and development of new dosage forms
- Pre formulation studies
- Lab / pilot scale studies
- Process optimization/validation studies
- Stability studies as per ICH guidance
- Technology transfer of new products
- Technical supports to manufacturing location
- Technology and latest development up gradation to provide technically superior process efficient and International standards product.